NEW YORK (GenomeWeb News) – The plaintiff in a lawsuit that accused Sequenom of capping the price of its MaterniT21 Plus non-invasive prenatal test in order to drive up its adoption has dropped her case.

The plaintiff Bette Borenstein voluntarily dismissed her lawsuit earlier this week in US District Court for the Southern District of California five months after initiating the litigation. No reason was provided in court papers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.